Keratin 18 is considered as a differentiation and epithelial marker, indicating differentiation and mesenchymal-epithelial transition (MET) of breast cancer cells [42, 43], while Vimentin functions as a dedifferentiation and mesenchymal marker in breast cancer cells [44, 45]. The gene discussed is VIM; the disease is breast carcinoma.